Shedding new light on atherosclerosis therapeutics: Nanomedicines targeting atherosclerotic immune microenvironment
Atherosclerosis (AS) leads to atherosclerotic cardiovascular disease (ASCVD), the predominant cause of death worldwide. As traditional lipid-lowering therapies have encountered a bottleneck in dealing with diverse types of atherosclerotic plaques and ASCVD, alternative therapies that can target othe...
Saved in:
Main Authors: | Zhiyue Wang, Jie Sheng, Guangming Lu, Longjiang Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-12-01
|
Series: | EngMedicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2950489924000435 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immunometabolism of Tregs: mechanisms, adaptability, and therapeutic implications in diseases
by: Yuming Lu, et al.
Published: (2025-01-01) -
Therapeutic Innovations in Nanomedicine: Exploring the Potential of Magnetotactic Bacteria and Bacterial Magnetosomes
by: Yadav VK, et al.
Published: (2025-01-01) -
Role of Nanomedicine and Nanotechnology in Dentistry – A Narrative Review
by: Richa Singh, et al.
Published: (2024-12-01) -
Recent advances in self-targeting natural product-based nanomedicines
by: Haifan Liu, et al.
Published: (2025-01-01) -
Unraveling the Role of the Tumor Extracellular Matrix to Inform Nanoparticle Design for Nanomedicine
by: Marco Cassani, et al.
Published: (2025-01-01)